Article
Advances in Gene Therapy for Hemophilia
24 Aug 2017
Abstract excerpt
Gene therapy provides hope for a cure for patients with hemophilia by establishing continuous endogenous expression of factor VIII or factor IX following transfer of a functional gene copy to replace the hemophilic patient's own defective gene. Hemophilia may be considered a "low-hanging fruit" for gene therapy because a small increment in blood factor levels (≥2% of normal) significantly improves the bleeding...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
